Investment
Features
FeesSafety
Academy
More
Pluang+

Humana shares jump as Medicare Advantage contract earns 4-star rating for 2027, boosting profit outlook.

Analyst Insights
09 Oct 2026
Seeking Alpha
View Source
Bullish
Humana shares jump as Medicare Advantage contract earns 4-star rating for 2027, boosting profit outlook.

Humana's stock surged after its main Medicare Advantage plan regained a 4-star rating for 2027 from the Centers for Medicare and Medicaid Services, up from 3.5 stars in 2026. This upgrade means 95% of Humana's Medicare Advantage members will be in plans that receive a 5% benchmark rate advantage, significantly improving the company's profit potential. Despite the strong fundamentals and technical breakout, the stock appears fairly valued after a 64% rally since last year, leading the analyst to maintain a "Hold" rating. Investors might consider waiting for a dip near $400 for a better entry point amid ongoing market volatility and regulatory sensitivity.

Humana's stock price on Pluang stands at USD 433.00 as of Oct 10, 2026, showing a strong 1-day gain of 11.85%, which highlights the market's positive reaction compared to its typical hold time of 51 days. Despite the recent surge, the stock's dividend yield remains modest at 0.91%, and buying interest dominates with 93% of orders being buys. This contrasts with the analyst's caution to hold after a significant 64% rally over the past year, indicating a balance between momentum and valuation concerns.

More News (HUM)

Oppenheimer raises Humana price target to $475 on strong Medicare Advantage ratings.

Oppenheimer raises Humana price target to $475 on strong Medicare Advantage ratings.

Oppenheimer upgraded Humana's price target from $405 to $475, citing strong performance in Medicare Advantage plans where 95% of members are in four-star or higher rated plans. This upgrade implies a potential 22.7% upside from Humana's current stock...

Analyst Insights
Bullish
11 hours ago
Medicare Advantage plans with 4+ stars drop 18%, but enrollment in top plans rises, signaling rating changes, not care quality.

Medicare Advantage plans with 4+ stars drop 18%, but enrollment in top plans rises, signaling rating changes, not care quality.

The Centers for Medicare & Medicaid Services (CMS) announced an 18% drop in Medicare Advantage contracts rated four stars or higher for 2027, due to changes in rating criteria including new medication-safety measures and increased weight on physical ...

Market News
Neutral
13 hours ago
Humana shares jump 15% as 95% of Medicare Advantage members qualify for 4-star plans in 2027

Humana shares jump 15% as 95% of Medicare Advantage members qualify for 4-star plans in 2027

Humana's shares rose nearly 15% after the company improved its Medicare Advantage quality ratings for 2027, with about 95% of members enrolled in plans rated at least four stars. The company now has 18 contracts rated four stars or higher, including ...

Market News
Bullish
14 hours ago
Humana shares jump 16% on improved Medicare Advantage Star Ratings; CVS falls 3%, UnitedHealth steady.

Humana shares jump 16% on improved Medicare Advantage Star Ratings; CVS falls 3%, UnitedHealth steady.

Humana's stock surged 16% after the company announced improved Medicare Advantage Star Ratings for 2027, with 95% of its members enrolled in plans rated four stars or higher. This improvement reflects better preventive care and earlier disease detect...

Market News
Bullish
15 hours ago
Medicare Advantage plans are shutting down, risking coverage changes for nearly 1M members.

Medicare Advantage plans are shutting down, risking coverage changes for nearly 1M members.

Nearly 1 million Medicare Advantage members face plan shutdowns from providers like UnitedHealth and Humana, risking loss of current coverage. While this reduces insurer costs and improves margins, affected members must act by December 7 to secure Me...

Market News
Neutral
2 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App